The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $31.82 down -5.58% from its previous closing price of $33.70. In other words, the price has decreased by -$5.58 from its previous closing price. On the day, 0.51 million shares were traded. KYMR stock price reached its highest trading level at $34.1 during the session, while it also had its lowest trading level at $31.525.
Ratios:
For a deeper understanding of Kymera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.53 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $52.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $60.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $55.BMO Capital Markets initiated its Market Perform rating on December 06, 2024, with a $55 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when Chiniara Ellen sold 2,241 shares for $30.45 per share. The transaction valued at 68,239 led to the insider holds 80,085 shares of the business.
Chadwick Jeremy G sold 1,383 shares of KYMR for $42,113 on Mar 03 ’25. The Chief Operating Officer now owns 67,800 shares after completing the transaction at $30.45 per share. On Mar 03 ’25, another insider, Jacobs Bruce N., who serves as the Chief Financial Officer of the company, sold 7,035 shares for $30.45 each. As a result, the insider received 214,219 and left with 201,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 2188617728 and an Enterprise Value of 1665539456. For the stock, the TTM Price-to-Sale (P/S) ratio is 43.90 while its Price-to-Book (P/B) ratio in mrq is 2.47. Its current Enterprise Value per Revenue stands at 35.383 whereas that against EBITDA is -6.643.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.18, which has changed by -0.20786655 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $29.07. The 50-Day Moving Average of the stock is -12.95%, while the 200-Day Moving Average is calculated to be -23.35%.
Shares Statistics:
For the past three months, KYMR has traded an average of 580.82K shares per day and 584840 over the past ten days. A total of 64.89M shares are outstanding, with a floating share count of 53.96M. Insiders hold about 16.91% of the company’s shares, while institutions hold 95.07% stake in the company. Shares short for KYMR as of 1740700800 were 7575085 with a Short Ratio of 13.04, compared to 1738281600 on 7690384. Therefore, it implies a Short% of Shares Outstanding of 7575085 and a Short% of Float of 13.020000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The firm’s stock currently is rated by 15.0 analysts. The consensus estimate for the next quarter is -$0.91, with high estimates of -$0.57 and low estimates of -$1.09.
Analysts are recommending an EPS of between -$2.42 and -$4.72 for the fiscal current year, implying an average EPS of -$3.74. EPS for the following year is -$4.2, with 16.0 analysts recommending between -$2.68 and -$5.99.
Revenue Estimates
A total of 21 analysts have provided revenue estimates for KYMR’s current fiscal year. The highest revenue estimate was $140M, while the lowest revenue estimate was $13.6M, resulting in an average revenue estimate of $62.45M. In the same quarter a year ago, actual revenue was $47.07M
